Pharma Journalist -

GE HealthCare announced that the U.S. Food and Drug Administration (FDA) has approved an updated label for its PET imaging agent Vizamyl™ (flutemetamol F 18 injection), used for…
Read More...

GSK plc has announced that the U.S. Food and Drug Administration (FDA) has approved a 200 mg/mL autoinjector form of Benlysta (belimumab) for subcutaneous injection in pediatric…
Read More...

Gilead Sciences, Inc. and Kymera Therapeutics, Inc. have announced an exclusive option and license agreement aimed at advancing a novel class of cancer treatments: molecular glue…
Read More...

Eli Lilly and Company announced that the U.S. FDA has approved a label update for Amyvid (florbetapir F 18 injection) for intravenous use. Amyvid is used for brain imaging to estimate…
Read More...

Vor Bio, Inc. has entered into an exclusive global licensing agreement with Chinese biopharmaceutical company RemeGen Co., Ltd., gaining rights to develop and commercialize the…
Read More...

Medera Inc., a clinical-stage biopharmaceutical company focused on cardiovascular disease therapies, and its pre-clinical subsidiary Novoheart, specializing in human cardiac tissue…
Read More...

Novo Nordisk announced that the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has given a positive opinion to update the label of Ozempic…
Read More...

The U.S. Food and Drug Administration (FDA) has granted accelerated approval for Datroway (datopotamab deruxtecan or Dato-DXd) for the treatment of adult patients with locally advanced…
Read More...

argenx SE, a global immunology company committed to improving the lives of people suffering from severe autoimmune diseases, announced that the European Commission (EC) approved VYVGART…
Read More...

Harbour BioMed, a global biopharmaceutical company committed to the discovery and development of novel antibody therapeutics in immunology and oncology, announced a global strategic…
Read More...